Nanolive hosts this event on “Non-invasive, high content live cell assays to increase translational relevance of in vitro drug development of biologics and small molecules”.
In this webinar, we present the following use-cases of our immuno-oncology and cytotoxicity assays from industry-leading biopharma companies to test toxicity, selectivity, uptake and expression of different targeted therapies.
- Immune cell therapeutics:
- Bispecific antibody screening in a T cell-target cell co-culture (Light Chain Bioscience)
- Drug selectivity and cytotoxicity:
- mRNA expression and cytotoxicity (TRON)
- Drug selectivity in co-cultures: senolytics (dsm-firmenich)
- Measuring particle uptake (bit.bio)
This webinar lasts 20 to 25 minutes.
Read our latest news
Seminar – Label-Free Live Cell Analysis: Applications in Cancer Cell Death and Immune Engineering
Get a look into Nanolive’s workflow in this on-demand Online Demo, as our Field Application Specialist, Matthias Schade, guides us through the insights gained from a high content phenotypic screen.
Measuring CAR T potency with label-free imaging
Discover case study data from scientists at UPenn demonstrating a label-free CAR T cytotoxicity assay, with high resolution CAR T cell images.
Online demo: Rethink high content screening workflows for smarter decisions
Get a look into Nanolive’s workflow in this on-demand Online Demo, as our Field Application Specialist, Matthias Schade, guides us through the insights gained from a high content phenotypic screen.